Aquestive Therapeutics, Inc. (AQST)
5.02
-0.14
(-2.71%)
USD |
NASDAQ |
Aug 28, 16:00
5.02
0.00 (0.00%)
After-Hours: 20:00
Aquestive Therapeutics Free Cash Flow : -45.95M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -45.95M |
| March 31, 2026 | -44.32M |
| December 31, 2025 | -52.99M |
| September 30, 2025 | -50.94M |
| June 30, 2025 | -50.02M |
| March 31, 2025 | -49.04M |
| December 31, 2024 | -35.92M |
| September 30, 2024 | -34.37M |
| June 30, 2024 | -24.91M |
| March 31, 2024 | -26.60M |
| December 31, 2023 | -7.375M |
| September 30, 2023 | 6.003M |
| June 30, 2023 | 9.593M |
| March 31, 2023 | 11.09M |
| December 31, 2022 | -12.31M |
| September 30, 2022 | -29.33M |
| June 30, 2022 | -39.57M |
| March 31, 2022 | -34.28M |
| Date | Value |
|---|---|
| December 31, 2021 | -33.89M |
| September 30, 2021 | -39.05M |
| June 30, 2021 | -38.25M |
| March 31, 2021 | -46.41M |
| December 31, 2020 | -45.98M |
| September 30, 2020 | -42.89M |
| June 30, 2020 | -49.42M |
| March 31, 2020 | -56.58M |
| December 31, 2019 | -60.87M |
| September 30, 2019 | -58.28M |
| June 30, 2019 | -53.80M |
| March 31, 2019 | -38.16M |
| December 31, 2018 | -19.58M |
| September 30, 2018 | -19.01M |
| June 30, 2018 | 6.582M |
| March 31, 2018 | 1.031M |
| December 31, 2017 | 3.756M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| LENZ Therapeutics, Inc. | -114.42M |
| ANI Pharmaceuticals, Inc. | 167.52M |
| Corcept Therapeutics, Inc. | 106.92M |
| Veru, Inc. | -26.04M |
| Johnson & Johnson | 22.61B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -9.441M |
| Cash from Investing (Quarterly) | -0.212M |
| Cash from Financing (Quarterly) | -2.591M |
| Free Cash Flow Per Share (Quarterly) | -0.0772 |
| Free Cash Flow to Equity (Quarterly) | -25.16M |
| Free Cash Flow to Firm (Quarterly) | -5.813M |
| Free Cash Flow Yield | -7.63% |